ZLD 2.86% 72.0¢ zelira therapeutics limited

Ann: Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 776 Posts.
    lightbulb Created with Sketch. 65
    If this company is trying to say there was no evidence to suggest reduction in pain score however assisted with depression and anxiety on 7 patients as statically significant and conclusive is a complete joke!


    but hey, pharmacokinetics says it’s safe

    moving forward
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.